UK markets open in 6 hours 10 minutes

Enovis Corporation (0I1B.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
55.55-1.67 (-2.91%)
At close: 04:02PM BST

Enovis Corporation

2711 Centerville Road
Suite 400
Wilmington, DE 19808
United States
302 252 9160
https://www.enovis.com

Sector(s)
Industry
Full-time employees6,550

Key executives

NameTitlePayExercisedYear born
Mr. Matthew L. TrerotolaCEO & Chairman3.35MN/A1967
Mr. Phillip Benjamin BerrySenior VP & CFO1.08MN/A1979
Ms. Patricia A. LangSenior VP & Chief Human Resources Officer1.01MN/A1959
Mr. Daniel A. PryorExecutive Vice President of Strategy & Business Development1.29MN/A1968
Mr. Brady R. ShirleyExecutive Advisor & Director2.02MN/A1966
Mr. John KlecknerVP, Controller & Chief Accounting OfficerN/AN/A1977
Derek LeckowVice President of Investor RelationsN/AN/AN/A
Mr. Bradley J. TandySenior VP & Chief Legal OfficerN/AN/A1959
Katie SweetVice President of Corporate CommunicationN/AN/AN/A
Mr. Terry RossGroup President Prevention & RecoveryN/AN/A1970
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Corporate governance

Enovis Corporation’s ISS governance QualityScore as of 1 April 2024 is 2. The pillar scores are Audit: 5; Board: 2; Shareholder rights: 2; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.